Artes Medical to Announce Financial Results for the Quarter Ended September 30, 2007

SAN DIEGO--(BUSINESS WIRE)--Nov. 8, 2007--Artes Medical, Inc. (Nasdaq:ARTE), a medical technology company whose product ArteFill(R) is the first and only FDA-approved non-resorbable injectable dermal filler for the correction of "smile line" wrinkles, announced that it will release its financial results for the quarter ended September 30, 2007 on Tuesday, November 13, 2007 at 1:30 p.m. Pacific Time.

Artes Medical will host a webcast and conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on November 13, 2007 to discuss the financial results. The dial in numbers are (866) 700-7477 for domestic callers, and (617) 213-8840 for international callers. The passcode for both domestic and international callers is 61763260. A live webcast of the conference call will be available online from the investor relations page of the Company's corporate website at www.artesmedical.com. Participating in the call will be Diane S. Goostree, President and Chief Executive Officer and Peter C. Wulff, Executive Vice President and Chief Financial Officer.

After the live web cast the call will remain available on Artes Medical's web site for at least 30 days following presentation. In addition, a telephonic reply of the call will be available for 7 days. The replay dial-in numbers are (888) 286-8010 for domestic callers, and (617) 801-6888 for international callers. The passcode for both domestic and international callers is 81923092.

About Artes Medical, Inc.

Artes Medical is a medical technology company focused on developing, manufacturing and commercializing a new category of aesthetic injectable products for the dermatology and plastic surgery markets. The Company's initial product, ArteFill, is being marketed to men and women as a treatment option for the correction of nasolabial folds. There were approximately two million dermal filler procedures in the U.S. in 2006, an increase of 25% over the prior year, according to the American Society for Aesthetic Plastic Surgery, or ASAPS. Additional information about Artes Medical and ArteFill is available at www.artesmedical.com and www.artefill.com.

Artes Medical(R) and ArteFill(R) are registered trademarks of Artes Medical, Inc.

CONTACT: Artes Medical, Inc.
Cheryl Monblatt Allen, 858-550-9999 (Investor Relations)
callen@artesmedical.com or
Schwartz Communications, Inc.
Thea Lavin, 415-512-0770 (Corporate Media)
artes@schwartz-pr.com

SOURCE: Artes Medical, Inc.